Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Commons Clinic is a multi-specialty clinic offering minimally-invasive surgical and conservative musculoskeletal care.
Vesta Healthcare is a technology and clinical services organization that offers virtual care services.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.
Pahr Therapeutics is a clinical stage business, is to create innovative ways to treat pulmonary arterial hypertension.
Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Freenome is a biotechnology company developing blood tests for early cancer detection to improve access to routine screening.
LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Ocelot Bio brings new treatment options to patients with severe liver disease.
AM Batteries manufactures Li-ion batteries using solvent-free electrode manufacturing technology.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
RA Capital Management has invested in 455 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 23 different industry categories.
Among tracked funding rounds, Tango Therapeutics received $600.0M in a Post-IPO Equity round. RA Capital Management's total known invested capital is $44.0B.
RA Capital Management's average investment size is $125.7M across its portfolio of 455 companies.
Recent RA Capital Management portfolio additions include Sydnexis, Alchemab Therapeutics, Commons Clinic, Vesta Healthcare, Day One Biopharmaceuticals. These companies were founded in 2020 or later.